Idiopathic Pulmonary Fibrosis Management Market is expected to reach US$ 3649.90 Million by 2033 | FMI

The global Idiopathic Pulmonary Fibrosis Management Market is expected to generate a market value of US$ 3145 Million in 2023 and a market value of US$ 3649.90 Million by 2033, with a CAGR of 1.5% from 2023 to 2033. The increasing prevalence of the disease in males around the world has contributed to the growth …

The Global Encephalitis Treatment Market Is Expected to Register Growth at 5.4% CAGR through 2033 | FMI Study

The global Encephalitis Treatment Market is currently valued at US$ 20.14 billion in 2023, with a CAGR of 5.4% expected. Because of technological advancements in healthcare, the market is expected to reach US$ 34.08 billion by 2033. The major factor attributing to the growth of the market is the high mortality and morbidity rate caused …

Cardiovascular Ultrasound Market is expected to reach a US$ 2.6 billion valuation by 2033 | FMI Study

The Cardiovascular Ultrasound Market revenues were estimated at US$ 1.2 Billion in 2021 and is anticipated to grow at a CAGR of 7.2% from 2022-2032, according to a recently published Future Market Insights report. By the end of 2032, the market is expected to reach US$ 2.6 Billion. The market is predicted to grow as …

Liver Fibrosis Treatment Market to surge at an 11% CAGR until 2033, reaching US$ 46.65 billion | FMI Study

The global Liver Fibrosis Treatment Market is anticipated to exceed a remarkable valuation of US$ 16.43 billion in 2023, with a compound annual growth rate (CAGR) of 11% projected from 2023 to 2033. The rising prevalence of undesirable outcomes such as hepatitis B or C virus infection, an impaired immune system due to co-infection with …

Next Generation Immunotherapies Market to reach US$ 268.84 billion by 2033, Monoclonal Antibodies were Primary Drug Class | FMI Report

The global Next Generation Immunotherapies Market is estimated to exceed a spectacular valuation of US$ 268.84 billion in 2033, with a compound annual growth rate (CAGR) of 7.5% projected from 2023 to 2033. The vast majority of present immunotherapies, such as checkpoint inhibitors, seek to enhance the immune system’s adaptive response, precisely cytotoxic T cells, …

Synthetic Biology Market to reach a valuation of ~US$ 138.8 Billion by the year 2032

The global synthetic biology market is expected to be worth US$ 15.8 billion by the end of 2022, and to grow at a CAGR of 24.3% to be worth US$ 138.8 billion by 2032. According to a recent study by Future Market Insights, the oligonucleotides segment by product will lead the market with a share of approximately …

Heterozygous Familial Hypercholesterolemia (HEFH) Management Market is expected to grow at a 14.5% CAGR from 2023 to 20232

In fiscal year 2023, the market for managing heterozygous familial hypercholesterolemia (HEFH) management is anticipated to be valued US$ 15.11 Billion, up from US$ 13.2 billion in fiscal year 2022. The worldwide market is anticipated to expand at a constant 14.5% CAGR from 2023 to 2033, reaching a value of US$ 58.54 Billion by the end of …

Arthroscopy Visualization Systems Market estimated to surge ahead at a CAGR value of 7.1% from 2022 to 2032

According to Future Market Insights’ latest industry analysis, the market size for the global arthroscopy visualization systems market is expected to reach US$ 453.8 Mn in 2022. It is projected to exhibit growth at a CAGR of 7.1% over the forecast period, with estimated market size of US$ 902.5 Mn in 2032. The high demand for arthroscopy visualization systems due to an increase …

Synthetic Biology Market to reach a valuation of ~US$ 138.8 Billion by the year 2032.

The global synthetic biology market is expected to be worth US$ 15.8 billion by the end of 2022, and to grow at a CAGR of 24.3% to be worth US$ 138.8 billion by 2032. According to a recent study by Future Market Insights, the oligonucleotides segment by product will lead the market with a share of approximately …

Plant-based Fish Feed Market is Set to Grow at 6% CAGR Through 2032 at a value of US$ 12.2 Billion

The plant-based fish feed market is valued at US$ 6.8 Bn in 2021. It is set to grow at 6% CAGR through 2032 at a value of US$ 12.2 Bn. Fish feeds are pellets or granules that give fish nutrients and help them reach their maximum potential. Soybean, canola oil, lipids from algae sources, and amino acid additions are used to make …